A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical TrialSai‐Hong Ignatius Ou, Trever G. Bivona, Susanna V. Ulahannan et al.|Journal of Thoracic Oncology|2020Cited by 74